Status: current, Defined. Date: 30-Jun 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3394971000168117 | Lixisenatide Treatment Initiation Pack (Sanofi) (lixisenatide 10 microgram / 0.2 mL) injection [1 x 3 mL pen device] (&) (lixisenatide 20 microgram / 0.2 mL) injection [1 x 3 mL pen device], 1 pack (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3394981000168119 | Lixisenatide Treatment Initiation Pack (Sanofi) (1 x Lyxumia 10 microgram/0.2 mL pen device, 1 x Lyxumia 20 microgram/0.2 mL pen device), 1 pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lixisenatide Treatment Initiation Pack (Sanofi) (1 x Lyxumia 10 microgram/0.2 mL pen device, 1 x Lyxumia 20 microgram/0.2 mL pen device), 1 pack | Is a | lixisenatide 10 microgram/0.2 mL injection [3 mL pen device] (&) lixisenatide 20 microgram/0.2 mL injection [3 mL pen device], 1 pack | true | Inferred relationship | Some | ||
| Lixisenatide Treatment Initiation Pack (Sanofi) (1 x Lyxumia 10 microgram/0.2 mL pen device, 1 x Lyxumia 20 microgram/0.2 mL pen device), 1 pack | Is a | trade product pack | true | Inferred relationship | Some | ||
| Lixisenatide Treatment Initiation Pack (Sanofi) (1 x Lyxumia 10 microgram/0.2 mL pen device, 1 x Lyxumia 20 microgram/0.2 mL pen device), 1 pack | has TPUU | Lyxumia 10 microgram/0.2 mL injection, 3 mL pen device | true | Inferred relationship | Some | 2 | |
| Lixisenatide Treatment Initiation Pack (Sanofi) (1 x Lyxumia 10 microgram/0.2 mL pen device, 1 x Lyxumia 20 microgram/0.2 mL pen device), 1 pack | has TPUU | Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device | true | Inferred relationship | Some | 1 | |
| Lixisenatide Treatment Initiation Pack (Sanofi) (1 x Lyxumia 10 microgram/0.2 mL pen device, 1 x Lyxumia 20 microgram/0.2 mL pen device), 1 pack | has component pack | lixisenatide 10 microgram / 0.2 mL injection, 1 x 3 mL pen device (medicinal product pack) | true | Inferred relationship | Some | ||
| Lixisenatide Treatment Initiation Pack (Sanofi) (1 x Lyxumia 10 microgram/0.2 mL pen device, 1 x Lyxumia 20 microgram/0.2 mL pen device), 1 pack | has component pack | lixisenatide 20 microgram/0.2 mL injection, 3 mL pen device | true | Inferred relationship | Some | ||
| Lixisenatide Treatment Initiation Pack (Sanofi) (1 x Lyxumia 10 microgram/0.2 mL pen device, 1 x Lyxumia 20 microgram/0.2 mL pen device), 1 pack | has TP | Lixisenatide Treatment Initiation Pack (Sanofi) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lixisenatide Treatment Initiation Pack (Sanofi) (1 x Lyxumia 10 microgram/0.2 mL pen device, 1 x Lyxumia 20 microgram/0.2 mL pen device), 1 pack | Is a | True | Lixisenatide Treatment Initiation Pack (Sanofi) (1 x Lyxumia 10 microgram/0.2 mL pen device, 1 x Lyxumia 20 microgram/0.2 mL pen device), 1 pack | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR